Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →
Upstream Biotechnology raises seed funding led by LeVert Ventures to develop their 'SwitchBlade' crop defense technology.
PUBLIC · UPBJul 30, 2026•10 days ago
Round Type
Seed
WalthamBiotechnologyHealth CareScience And Engineering
Investors
Vtc VenturesSilver BlueCorteva CatalystLe Vert Ventures
Description
Upstream Biotechnology has successfully secured seed funding to advance its innovative crop defense technology. The funding round was led by LeVert Ventures with participation from Corteva Catalyst, Silver Blue, VTC Ventures, among others. Their technology aims to allow plants to activate disease resistance only when necessary, maintaining growth during normal conditions. This breakthrough could lead to enhanced agricultural resilience and improved yield.
Company Information
Company
Upstream Bio
Location
Waltham, Massachusetts, United States
About
At Upstream Bio we strive to reach the source of inflammation and conquer it. Our lead program is a clinical-stage monoclonal antibody that inhibits the TSLP receptor. TSLP is a validated target positioned upstream of multiple signaling cascades that affect a variety of immune cells pivotal to common and rare diseases. We are leveraging our diverse roots and the team’s substantial industry experience to develop therapies that ease the burden of inflammatory and allergic diseases on patients and their loved ones. https://www.upstreambio.com/
Related People
Suggested for you
1 contact
Verified contactsNo contacts on file at Upstream Bio yet.
Predictive Intelligence
Strategic
ML-powered predictions for Upstream Bio's next move
WalthamBiotechnologyHealth CareScience And Engineering